Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Why are Behçet's disease patients always exhausted?

Senusi AA, Liu J, Bevec D, Bergmeier LA, Stanford M, Kidd D, Jawad A, Higgins S, Fortune F.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):53-62. Epub 2018 Oct 5.

2.

The influence of oral health and psycho-social well-being on clinical outcomes in Behçet's disease.

Senusi A, Higgins S, Fortune F.

Rheumatol Int. 2018 Oct;38(10):1873-1883. doi: 10.1007/s00296-018-4117-y. Epub 2018 Aug 27.

3.

Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Dec 1;57(12):2200-2212. doi: 10.1093/rheumatology/key242.

PMID:
30107448
4.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2018 May 19. pii: S0049-0172(18)30240-3. doi: 10.1016/j.semarthrit.2018.05.008. [Epub ahead of print]

PMID:
29954598
5.

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID:
29625968
6.

Behçet's syndrome and health-related quality of life: influence of symptoms, lifestyle and employment status.

Senusi AA, Ola D, Mather J, Mather J, Fortune F.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):43-50. Epub 2017 Jun 8.

7.

The Behçet's centres of excellence.

Moots RJ, Fortune F, Situnayake D.

Rheumatology (Oxford). 2018 Apr 1;57(4):594-595. doi: 10.1093/rheumatology/kex037. No abstract available.

PMID:
28340170
8.

Circulating NK cells and their subsets in Behçet's disease.

Hasan MS, Ryan PL, Bergmeier LA, Fortune F.

Clin Exp Immunol. 2017 May;188(2):311-322. doi: 10.1111/cei.12939. Epub 2017 Mar 13.

9.

Fluoride incorporation in high phosphate containing bioactive glasses and in vitro osteogenic, angiogenic and antibacterial effects.

Liu J, Rawlinson SCF, Hill RG, Fortune F.

Dent Mater. 2016 Oct;32(10):e221-e237. doi: 10.1016/j.dental.2016.07.003. Epub 2016 Jul 25.

PMID:
27461261
10.

Strontium-substituted bioactive glasses in vitro osteogenic and antibacterial effects.

Liu J, Rawlinson SC, Hill RG, Fortune F.

Dent Mater. 2016 Mar;32(3):412-22. doi: 10.1016/j.dental.2015.12.013. Epub 2016 Jan 8.

PMID:
26777094
11.

Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.

Hasan MS, Bergmeier LA, Petrushkin H, Fortune F.

J Immunol Res. 2015;2015:705831. doi: 10.1155/2015/705831. Epub 2015 Oct 11. Review.

12.

Improving morbidity and mortality in peripheral ulcerative keratitis associated with rheumatoid arthritis.

Petrushkin HJ, Stanford M, Fortune F, Jawad A.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1 Suppl 95):S18-9. Epub 2015 Oct 30. No abstract available.

13.

Genital ulcer severity score and genital health quality of life in Behçet's disease.

Senusi A, Seoudi N, Bergmeier LA, Fortune F.

Orphanet J Rare Dis. 2015 Sep 22;10:117. doi: 10.1186/s13023-015-0341-7.

14.

The seroprevalence and salivary shedding of herpesviruses in Behçet's syndrome and recurrent aphthous stomatitis.

Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Fortune F.

J Oral Microbiol. 2015 Jun 5;7:27156. doi: 10.3402/jom.v7.27156. eCollection 2015.

15.

The oral mucosal and salivary microbial community of Behçet's syndrome and recurrent aphthous stomatitis.

Seoudi N, Bergmeier LA, Drobniewski F, Paster B, Fortune F.

J Oral Microbiol. 2015 Jun 1;7:27150. doi: 10.3402/jom.v7.27150. eCollection 2015.

16.

Behçet's Disease: Do Natural Killer Cells Play a Significant Role?

Petrushkin H, Hasan MS, Stanford MR, Fortune F, Wallace GR.

Front Immunol. 2015 Mar 24;6:134. doi: 10.3389/fimmu.2015.00134. eCollection 2015. Review.

17.

Clinical Review: Familial Mediterranean Fever-An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment.

Petrushkin H, Stanford M, Fortune F, Jawad AS.

Ocul Immunol Inflamm. 2016 Aug;24(4):422-30. doi: 10.3109/09273948.2015.1010012. Epub 2015 Mar 11. Review.

PMID:
25760918
18.

Brown tumours: widespread involvement of multiple maxillofacial bones and cervical spine.

Gadhia T, Adegun OK, Fortune F.

BMJ Case Rep. 2014 Nov 14;2014. pii: bcr2014207140. doi: 10.1136/bcr-2014-207140. No abstract available.

19.

Differential expression of suppressor of cytokine signalling proteins in Behçet's disease.

Hamedi M, Bergmeier LA, Hagi-Pavli E, Vartoukian SR, Fortune F.

Scand J Immunol. 2014 Nov;80(5):369-76. doi: 10.1111/sji.12211.

20.

Oral manifestation of plantar-palmar fibromatosis.

Adegun OK, Abdelghani A, Fortune F.

BMJ Case Rep. 2014 Aug 14;2014. pii: bcr2014204962. doi: 10.1136/bcr-2014-204962. No abstract available.

21.

Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.

Vartoukian SR, Tilakaratne WM, Seoudi N, Bombardieri M, Bergmeier L, Tappuni AR, Fortune F.

Clin Exp Immunol. 2014 Sep;177(3):618-29. doi: 10.1111/cei.12377.

22.

Type 2 diabetes risk screening in dental practice settings: a pilot study.

Wright D, Muirhead V, Weston-Price S, Fortune F.

Br Dent J. 2014 Apr;216(7):E15. doi: 10.1038/sj.bdj.2014.250.

PMID:
24722119
23.

Facial biometrics: a novel technique for evaluation of morphological changes in orofacial Crohn's disease.

Adegun OK, Zou L, Willis A, Fortune F.

BMJ Case Rep. 2013 Nov 20;2013. pii: bcr2013010460. doi: 10.1136/bcr-2013-010460. No abstract available.

24.

Oral health and impact on performance of athletes participating in the London 2012 Olympic Games: a cross-sectional study.

Needleman I, Ashley P, Petrie A, Fortune F, Turner W, Jones J, Niggli J, Engebretsen L, Budgett R, Donos N, Clough T, Porter S.

Br J Sports Med. 2013 Nov;47(16):1054-8. doi: 10.1136/bjsports-2013-092891. Epub 2013 Sep 24.

25.

The role of TLR2 and 4 in Behçet's disease pathogenesis.

Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Curtis MA, Fortune F.

Innate Immun. 2014 May;20(4):412-22. doi: 10.1177/1753425913498042. Epub 2013 Aug 12.

PMID:
23940075
26.

Glucocorticoid sensitivity in Behçet's disease.

Quax RA, van Laar JA, van Heerebeek R, Greiner K, Ben-Chetrit E, Stanford M, Wallace GR, Fortune F, Ghabra M, Soylu M, Hazes JM, Lamberts SW, Kappen JH, van Hagen PM, Koper JW, Feelders RA.

Endocr Connect. 2012 Oct 24;1(2):103-11. doi: 10.1530/EC-12-0056. Print 2012 Nov 1.

27.

Facial biometrics of peri-oral changes in Crohn's disease.

Zou L, Adegun OK, Willis A, Fortune F.

Lasers Med Sci. 2014 May;29(3):869-74. doi: 10.1007/s10103-013-1286-5. Epub 2013 Feb 24.

PMID:
23435800
28.

Quantitative optical coherence tomography of fluid-filled oral mucosal lesions.

Adegun OK, Tomlins PH, Hagi-Pavli E, Bader DL, Fortune F.

Lasers Med Sci. 2013 Sep;28(5):1249-55. doi: 10.1007/s10103-012-1208-y. Epub 2012 Sep 21.

PMID:
22996049
29.

Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics.

Tsang SM, Brown L, Gadmor H, Gammon L, Fortune F, Wheeler A, Wan H.

Exp Cell Res. 2012 Nov 1;318(18):2269-83. doi: 10.1016/j.yexcr.2012.07.002. Epub 2012 Jul 13.

30.

Organ-specific management and supportive care in chronic graft-versus-host disease.

Dignan FL, Scarisbrick JJ, Cornish J, Clark A, Amrolia P, Jackson G, Mahendra P, Taylor PC, Shah P, Lightman S, Fortune F, Kibbler C, Andreyev J, Albanese A, Hadzic N, Potter MN, Shaw BE; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation.

Br J Haematol. 2012 Jul;158(1):62-78. doi: 10.1111/j.1365-2141.2012.09131.x. Epub 2012 Apr 26.

PMID:
22533889
31.

Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing.

Pitiyage GN, Lim KP, Gemenitzidis E, Teh MT, Waseem A, Prime SS, Tilakaratne WM, Fortune F, Parkinson EK.

J Oral Pathol Med. 2012 Jul;41(6):454-62. doi: 10.1111/j.1600-0714.2012.01129.x. Epub 2012 Mar 3.

PMID:
22385081
32.

Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris.

Tsang SM, Brown L, Lin K, Liu L, Piper K, O'Toole EA, Grose R, Hart IR, Garrod DR, Fortune F, Wan H.

J Pathol. 2012 May;227(1):81-93. doi: 10.1002/path.3982. Epub 2012 Feb 17.

PMID:
22294297
33.

Proposed career pathway for clinical academic general dental practitioners.

Aggarwal VR, Palmer NO, Nelson P, Ladwa R, Fortune F.

Prim Dent Care. 2011 Oct;18(4):155-60. doi: 10.1308/135576111797512757.

PMID:
21968042
34.

Quantitative analysis of optical coherence tomography and histopathology images of normal and dysplastic oral mucosal tissues.

Adegun OK, Tomlins PH, Hagi-Pavli E, McKenzie G, Piper K, Bader DL, Fortune F.

Lasers Med Sci. 2012 Jul;27(4):795-804. doi: 10.1007/s10103-011-0975-1. Epub 2011 Aug 18.

PMID:
21850480
35.

Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.

Macey M, Hagi-Pavli E, Stewart J, Wallace GR, Stanford M, Shirlaw P, Fortune F.

Rheumatology (Oxford). 2011 Oct;50(10):1849-59. doi: 10.1093/rheumatology/ker177. Epub 2011 Jun 29.

PMID:
21719422
36.

TIRAP Ser180Leu polymorphism is associated with Behcet's disease.

Durrani O, Banahan K, Sheedy FJ, McBride L, Ben-Chetrit E, Greiner K, Vaughan RW, Kondeatis E, Hamburger J, Fortune F, Stanford MR, Murray PI, O'Neill LA, Wallace GR.

Rheumatology (Oxford). 2011 Oct;50(10):1760-5. doi: 10.1093/rheumatology/ker200. Epub 2011 Jun 24.

PMID:
21705416
37.

RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation.

Mannan T, Jing S, Foroushania SH, Fortune F, Wan H.

Cell Prolif. 2011 Aug;44(4):301-10. doi: 10.1111/j.1365-2184.2011.00765.x.

PMID:
21702856
38.

A systematic review of medical interventions for oral submucous fibrosis and future research opportunities.

Kerr AR, Warnakulasuriya S, Mighell AJ, Dietrich T, Nasser M, Rimal J, Jalil A, Bornstein MM, Nagao T, Fortune F, Hazarey VH, Reichart PA, Silverman S, Johnson NW.

Oral Dis. 2011 Apr;17 Suppl 1:42-57. doi: 10.1111/j.1601-0825.2011.01791.x. Review.

PMID:
21382138
39.

Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases.

Pitiyage GN, Slijepcevic P, Gabrani A, Chianea YG, Lim KP, Prime SS, Tilakaratne WM, Fortune F, Parkinson EK.

J Pathol. 2011 Apr;223(5):604-17. doi: 10.1002/path.2839. Epub 2011 Feb 21.

PMID:
21341274
40.

Scattering attenuation microscopy of oral epithelial dysplasia.

Tomlins PH, Adegun O, Hagi-Pavli E, Piper K, Bader D, Fortune F.

J Biomed Opt. 2010 Nov-Dec;15(6):066003. doi: 10.1117/1.3505019.

PMID:
21198177
41.

Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.

Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM, Lewis MP, Marshall JF, Fortune F, Tilakaratne WM, Hart IR, Thomas GJ.

J Pathol. 2011 Feb;223(3):366-77. doi: 10.1002/path.2786. Epub 2010 Oct 25.

PMID:
21171082
42.

Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src.

Tsang SM, Liu L, Teh MT, Wheeler A, Grose R, Hart IR, Garrod DR, Fortune F, Wan H.

PLoS One. 2010 Dec 3;5(12):e14211. doi: 10.1371/journal.pone.0014211.

43.

A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.

Teh MT, Parkinson EK, Thurlow JK, Liu F, Fortune F, Wan H.

J Oral Pathol Med. 2011 Jan;40(1):67-76. doi: 10.1111/j.1600-0714.2010.00951.x. Epub 2010 Oct 4.

PMID:
20923451
44.

Impact of Behçet's syndrome on health-related quality of life: influence of the type and number of symptoms.

Bernabé E, Marcenes W, Mather J, Phillips C, Fortune F.

Rheumatology (Oxford). 2010 Nov;49(11):2165-71. doi: 10.1093/rheumatology/keq251. Epub 2010 Jul 30.

PMID:
20675710
45.

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease.

Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O'Shea J, Wallace GR, Gadina M, Kastner DL, Gül A.

Nat Genet. 2010 Aug;42(8):698-702. doi: 10.1038/ng.625. Epub 2010 Jul 11.

46.

Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.

Waseem A, Ali M, Odell EW, Fortune F, Teh MT.

Oral Oncol. 2010 Jul;46(7):536-42. doi: 10.1016/j.oraloncology.2010.03.022. Epub 2010 Apr 18.

PMID:
20400365
47.

Oral cancer screening in the Bangladeshi community of Tower Hamlets: a social model.

Nunn H, Lalli A, Fortune F, Croucher R.

Br J Cancer. 2009 Dec 3;101 Suppl 2:S68-72. doi: 10.1038/sj.bjc.6605394.

48.

Low prevalence of NOD2 SNPs in Behçet's disease suggests protective association in Caucasians.

Kappen JH, Wallace GR, Stolk L, Rivadeneira F, Uitterlinden AG, van Daele PL, Laman JD, Kuijpers RW, Baarsma GS, Stanford MR, Fortune F, Madanat W, van Hagen PM, van Laar JA.

Rheumatology (Oxford). 2009 Nov;48(11):1375-7. doi: 10.1093/rheumatology/kep292. Epub 2009 Sep 11.

PMID:
19748964
49.

Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease.

Mumcu G, Niazi S, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S, Stanford M, Fortune F, Direskeneli H.

J Oral Pathol Med. 2009 May;38(5):406-9. doi: 10.1111/j.1600-0714.2009.00752.x. Epub 2009 Mar 2.

PMID:
19298505
50.

FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.

Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, Sugden D, Thurlow JK, Cheong SC, Teo SH, Wan H, Waseem A, Parkinson EK, Fortune F, Teh MT.

PLoS One. 2009;4(3):e4849. doi: 10.1371/journal.pone.0004849. Epub 2009 Mar 16.

Supplemental Content

Loading ...
Support Center